ProMIS Neurosciences Inc. Common Shares (ON) (PMN) Dividend History

ProMIS Neurosciences Inc. is a biotechnology company focused on developing precision medicines for neurodegenerative diseases. Utilizing its proprietary platforms, the company researches and develops antibody-based therapies targeting misfolded proteins involved in conditions such as Alzheimer’s disease and other neurodegenerative disorders. Headquartered in Toronto, Ontario, ProMIS aims to advance treatments that can modify disease progression and improve patient outcomes.

Suite 200, 1920 Yonge Street, Toronto, A6, M4S 3E2
Phone: 416-847-6898
Website: https://www.promisneurosciences.com

Dividend History

ProMIS Neurosciences Inc. Common Shares (ON) currently does not pay dividends

Company News

  • ProMIS Neurosciences secured $3 million in private financing through a PIPE offering, with an additional $9 million from warrant exercises, totaling approximately $12 million in gross proceeds to advance clinical development of PMN310 and support corporate operations.

    GlobeNewswire Inc.
  • Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms. Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Soligenix, Inc. (NASDAQ: SNGX) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA. Longeveron Inc. (NASDAQ: LGVN) surged 54% to $2.6350 following insider buys from multiple company executives. SuperCom Ltd. (NASDAQ: SPCB) shares gained 39.4% to $0.3849 after jumping around 18% on Friday. Piedmont Lithium Inc. (NYSE: PLL) shares gained 32.1% to $16.75 following a 5% decline on Friday. Snap One Holdings Corp. (NASDAQ: SNPO) surged 31.6% to $10.71 after the company announced that it will be acquired by Resideo Technologies. Organovo Holdings, Inc. (NASDAQ: ONVO) shares surged 30.9% to $1.32 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo. Kuke Music Holding Limited (NASDAQ: KUKE) jumped 27% to $2.7650. HUB Cyber Security Ltd. (NASDAQ: HUBC) gained 24% to $1.61 after gaining over 11% on Friday. Edgio, Inc. (NASDAQ: EGIO) gained 24% to $22.18. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) ...

    Benzinga
Page data last updated 09/06/2025 04:25:46 UTC